Remote Patient Monitoring Devices Market Expected to Be Emerging Market Evaluated By Global Players Abbott Laboratories, GE Healthcare, Omron Healthcare, Medtronic

Remote patient monitoring devices allow for digital collection of medical health data from one location and electronically transmit the information to health care providers to another location for recommendation and assessments. The monitoring devices collect wide range of healthcare data from the point of care, which includes blood pressure, blood oxygen levels, heart rates, electrocardiograms, vital signs and blood sugar. The data obtained through the devices is then transmitted to health professionals in facilities such as hospitals, intensive care units and nursing facilities. Healthcare is revolutionized by Health Information Technologies (HITs) by becoming mainstream tools to assist patients in decision-making and self-monitoring and consequently, driving a shift towards a care model centered on the use of digital and web-based tools.

For In depth Information Get Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/215

The global remote patient monitoring devices market is estimated to be valued at US$ 856.8 million in 2017 and is expected to witness a CAGR of 7.1 % during the forecast period (2017 – 2025).

Market Dynamics

The market is gaining significant traction due to rising prevalence rate of hypertension and diabetes. Management of these chronic conditions include a lifelong collaboration with the healthcare professionals. According to the World Health Organization 2012, an estimated 1.5 million deaths were directly caused by diabetes and another 2.2 million deaths were attributable to hyperglycemia or high blood glucose levels. The technological innovations and developments of remote monitoring products are contributing to the market growth. For instance, the FDA approval of CGM remote mobile communications device Dexcom SHARE, an accessory of Dexcom G4 PLATINUM Continuous Glucose Monitoring System, uses a secure wireless connection to transmit the glucose levels of a diabetic. With Dexcom SHARE, the glucose data can be easily monitored by parents and personal caregivers from a remote location. However, uneven reimbursement policies, economic instability in the developing countries and lack of operating knowledge are the factors restraining the market growth.

Market Taxonomy

This report segments the global remote patient monitoring devices market on the basis of product type, application, end user, and geography. On the basis of product type, the remote patient monitoring devices market is categorized into cardiac monitors, respiratory monitors, hematological monitors, vital signs monitors and others. On the basis of application, the remote patient monitoring devices market is categorized into cardiac arrhythmia, diabetes, ischemic diseases, hypertension, sleep apnea, chronic respiratory diseases and hyperlipidemia. On the basis of end-user, the remote patient monitoring devices market is categorized into hospitals, home care settings, long term care centers and others. For comprehensive understanding of market dynamics, the global remote patient monitoring devices market is analyzed across key geographical regions namely North America, Europe, Asia Pacific, Latin America, Africa, and Middle East. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.

Increasing prevalence of respiratory disorders drives the growth of remote patient monitoring devices market

The remote patient monitoring devices market is expected to grow drastically owing to the government regulations to control the rising healthcare costs, the technological innovations and developments of efficient self-monitoring products. The Patient Protection and Affordable Care Act, also known as Obamacare was implemented under the Hospital Readmissions Reduction Program by U.S. government to impose penalties to hospitals. According to the penalty, government had reduced up to 1% in the Medicare payment per patient for hospital readmission within 30 days in 2013, thereby, accelerating the growth of remote patient monitoring devices by the healthcare professionals. According to the Biomed Central Respiratory Research 2016, asthma and chronic obstructive pulmonary disease (COPD) are common chronic obstructive lung disorders characterized by variable airflow limitation and airway hyper responsiveness, affecting over 25 million people in the U.S. The patient monitoring devices are largely been validated as clinically effective tools for the management of disease. However, lack of trained professionals, insufficiency in maintaining the privacy and security of the medical data, lack of uniformity in device functionality and lack of general awareness of monitoring devices are the factors expected to hinder market growth of the global remote patient monitoring device market.

Inquire Here Before Purchase of Research Report @ https://www.coherentmarketinsights.com/insight/talk-to-analyst/215

Key companies covered as a part of this study include Abbott Laboratories, GE Healthcare, Omron Healthcare, Medtronic, St. Jude Medical, Smiths Medical, Philips Healthcare, F. Hoffmann-La Roche Ltd. And Kokinklijke Philips N.V. and St. Jude Medical.

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.